Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lin L et al. - The results indicate that FLLL11 and FLLL12 exhibit more potent activities than curcumin on the inhibition of STAT3, AKT, and HER-2/neu, as well as inhibit cancer cell growth and migration, and may thus have translational potential as chemopreventive or therapeutic agents for breast and prostate cancers.

Related Articles

Rethinking Screening for Breast Cancer and Prostate Cancer
JAMA, 10/23/09    Relevance Score: 83%%

Low cholesterol may be sign of undiagnosed cancer
Reuters, 11/04/09    Relevance Score: 82%%

New Drug Aims To Seek And Destroy Many Types Of Cancer
ScienceDaily, 10/07/09    Relevance Score: 82%%

New drug aims to seek and destroy many types of cancer
EurekAlert, 10/06/09    Relevance Score: 82%%

Breakthrough In Lab-on-chip For Fast Cancer Detection And Therapy
ScienceDaily, 10/29/09    Relevance Score: 81%%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address